Skip to main content
. 2020 Dec 10;9(5):418–426. doi: 10.1093/gastro/goaa088

Table 2.

Comparison of intestinal-ultrasound findings between patients with or without decision changes

Ultrasonographic finding All patients Patients with decision change after IUS (n=47) Patients without decision change after IUS (n=70) P-value
Bowel-wall segments with thickening ≥3 mm
 Terminal ileum 83 (70.9) 36 (76.6) 47 (67.1) <0.001
 Right colon 54 (46.2) 20 (42.6) 34 (48.6) ns
 Transverse colon 33 (28.2) 7 (14.9) 26 (37.1) ns
 Left-colon sigmoid 35 (29.9) 10 (21.3) 25 (35.7) ns
 Rectum 7 (6) 0 7 (10) <0.001
Any bowel segment with thickening ≥3 mm 98 (83.8) 40 (85.1) 58 (82.9) <0.001
Involvement pattern <0.001
 Transmural 35 (29.9) 19 (40.4) 16 (22.9)
 Mixed (stratified and transmural) 38 (32.5) 14 (29.8) 24 (34.3)
MFP 86 (73.5) 37 (78.7) 49 (70) <0.001
Ulcer presence 66 (56.4) 29 (61.7) 37 (52.9) 0.014
Strictures 32 (27.4) 22 (46.8) 10 (14.3) 0.017
Prestenotic dilatation 20 (17.1) 13 (27.7) 7 (10) <0.001
Rigidity 37 (31.6) 23 (48.9) 14 (20) ns
Lymphadenopathy 38 (32.5) 18 (38.3) 20 (28.6) ns
Fistula 22 (18.8) 11 (23.4) 11 (15.7) <0.001
Phlegmon/abscess 16 (13.7) 9 (19.1) 7 (10) <0.001
Fluid 19 (16.2) 12 (25.5) 7 (10) <0.001
Power Doppler score ≥2 71 (60.7) 30 (63.8) 41 (58.6) 0.002
Any sign of disease activity on ultrasound 99 (84.6) 41 (87.2) 58 (82.9) <0.001

Data are presented as n (%).

For comparisons between patients with or without decision changes, the McNemar test was used except for “involvement-pattern” comparisons, for which the marginal homogeneity test was preferred.

MFP, mesenteric fibrofatty proliferation; ns, non-significant.